Search results
US FDA approves Merck's pneumococcal vaccine for adults
Reuters· 7 hours ago, opens new tab said on Monday the U.S. Food and Drug Administration has approved its...
FDA Approves Merck's Vaccine For Adult Invasive Pneumococcal Disease
Market Watch· 7 hours agoPublished: June 17, 2024 at 5:50 p.m. ETShareResizeBy Emon ReiserThe Food and Drug Administration approved Merck's Capvaxive, a vaccine to prevent the invasive ...
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia,...
NBC New York· 7 hours agoThe Food and Drug Administration approved Merck's vaccine designed to protect adults from a bacteria...
Merck Get FDA Approval for Keytruda to Treat Endometerial Cancer
Morningstar· 7 hours agoMerck said its blockbuster cancer drug Keytruda has been approved for the treatment of adult patients with primary advanced or recurrent endometrial carcinoma ...
AstraZeneca’s lung cancer drug approved by US FDA for combination chemotherapy treatment | Invezz
Invezz· 17 hours agoAstraZeneca, the largest pharmaceutical group in Britain, announced that the U.S. Food and Drug...
Gateway - Quartz
Quartz· 20 minutes agoCustomers will be able to get a prescription for the drug from a licensed health care provider directly on the platform. The announcement comes as skyrocketing demand for ...
Drug approved as sickle cell disease treatment may help stabilize vision in rare genetic disease
Medical Xpress· 13 hours agoIn a new study, the team reports that a drug approved by the FDA for another condition may stabilize...
FDA approves Amgen’s BLINCYTO for acute lymphoblastic leukaemia
Pharmaceutical Technology via Yahoo Finance· 20 hours agoThe US Food and Drug Administration (FDA) has approved Amgen’s BLINCYTO (blinatumomab) for...
FDA approves generic Emflaza oral suspension for Duchenne muscular dystrophy
Medical Xpress· 14 hours agoThe U.S. Food and Drug Administration has approved the first generic version of Emflaza...
FDA Panel Votes Against MDMA-Assisted Talk Therapy | JD Supra
JD Supra· 10 hours agoOn June 4, 2024, a panel of experts advising the Food and Drug Administration (FDA) on the use of the psychedelic midomafetamine (MDMA) for post-traumatic ...
